On this episode of the JVRD Author’s Forum podcast, retina specialist Talisa E. de Carlo Forest, MD, discusses the article, “Menopausal Hormone Therapy and Conversion From Intermediate to Advanced Age-Related Macular Degeneration,” published in the Journal of VitreoRetinal Diseases.

Host Dr. Timothy Murray speaks with Dr. Forest about the study’s investigation of whether menopausal hormone therapy is associated with progression from intermediate age-related macular degeneration (AMD) to advanced disease. The study followed female patients with intermediate AMD and evaluated conversion to both advanced non-neovascular AMD and neovascular AMD.

The discussion explores the potential role of hormonal factors in AMD and the study’s finding that a history of menopausal hormone therapy use was not associated with an increased risk of progression to either form of advanced AMD. Dr. Forest also discusses the importance of studying sex-specific factors in AMD and how further research may help clarify the complex relationship between hormones and disease progression.

For more information, visit www.ASRS.org/JVRDForum.

Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. As the official peer-reviewed scientific journal of the American Society of Retina Specialists (ASRS), JVRD delivers rigorous, clinically meaningful research that informs and advances retina care worldwide. Join Editor-in-Chief Dr. Timothy Murray as he engages leading investigators in thoughtful discussions about the latest studies published in JVRD — highlighting practical insights, clinical pearls, and the real-world impact of emerging innovations in our field.

On this episode of the JVRD Author’s Forum podcast, retina specialist Manjot K. Gill, MD, MS, discusses her article, “Patients at Elevated Risk for Heart Failure Exhibit Reduced Retinal Perfusion,” published in the Journal of VitreoRetinal Diseases.

Host Dr. Timothy Murray speaks with Dr. Gill about the emerging field of oculomics and the potential for retinal imaging to detect systemic disease before clinical symptoms develop. Using OCT angiography (OCTA), the study evaluated patients at elevated 10-year risk for heart failure and found reduced retinal perfusion compared with age-matched controls.

The discussion highlights how retinal imaging may offer a noninvasive biomarker for identifying patients with subclinical cardiovascular disease, supporting earlier intervention and more personalized risk assessment. Dr. Gill also explores how advances in OCTA and artificial intelligence are expanding the role of the retina in understanding systemic health and disease.

For more information, visit www.ASRS.org/JVRDForum.

Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. As the official peer-reviewed scientific journal of the American Society of Retina Specialists (ASRS), JVRD delivers rigorous, clinically meaningful research that informs and advances retina care worldwide. Join Editor-in-Chief Dr. Timothy Murray as he engages leading investigators in thoughtful discussions about the latest studies published in JVRD — highlighting practical insights, clinical pearls, and the real-world impact of emerging innovations in our field.

On this episode of the JVRD Author’s Forum podcast, retina specialist Sally Ong discusses her article, “The Impact of Socioeconomic Deprivation on Anti–Vascular Endothelial Growth Factor Therapy and Ocular Response in Patients With Diabetic Macular Edema,” published in the Journal of VitreoRetinal Diseases.

Host Dr. Timothy Murray speaks with Dr. Ong about how socioeconomic disadvantage may affect anti-VEGF treatment and outcomes in patients with diabetic macular edema. Using the Area Deprivation Index (ADI), the study found no significant differences in injection frequency or retinal anatomy between groups, though patients with less socioeconomic disadvantage had better visual acuity at two years and were more likely to undergo cataract surgery. The discussion also highlights the importance of patient education, coordinated diabetes care, and proactive follow-up to help patients preserve vision.

For more information, visit www.ASRS.org/JVRDForum.

Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. As the official peer-reviewed scientific journal of the American Society of Retina Specialists (ASRS), JVRD delivers rigorous, clinically meaningful research that informs and advances retina care worldwide. Join Editor-in-Chief Dr. Timothy Murray as he engages leading investigators in thoughtful discussions about the latest studies published in JVRD — highlighting practical insights, clinical pearls, and the real-world impact of emerging innovations in our field.